American Journal of Kidney Diseases
Volume 55, Issue 6 , Pages 1136-1141 , June 2010

Plasma Cell Dyscrasia Causing Light Chain Tubulopathy Without Fanconi Syndrome

  • Matthew R. Elliott, MD

      Affiliations

    • Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • ,
  • Cherise Cortese, MD

      Affiliations

    • Department of Pathology, Mayo Clinic, Jacksonville, FL
  • ,
  • Alvaro Moreno-Aspitia, MD

      Affiliations

    • Division of Hematology-Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL
  • ,
  • Jamie P. Dwyer, MD

      Affiliations

    • Division of Nephrology/Hypertension, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN
    • Nephrology Clinical Trials Center, Vanderbilt University Medical Center, Nashville, TN
    • Corresponding Author InformationAddress correspondence to Jamie P. Dwyer, MD, Division of Nephrology/Hypertension, Vanderbilt University Medical Center, MCN S-3223, Nashville, TN 37232

Received 20 April 2009 ,Accepted 6 August 2009.

References 

  1. Said SM, Assaad AM, Cerda J, Nasr SH. Light chain tubulopathy without Fanconi syndrome. Nephrol Dial Transplant. 2006;21:3589–3590
  2. Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Holley KE, Salassa RM. Fanconi syndrome in adults (A manifestation of a latent form of myeloma). Am J Med. 1975;58:354–364
  3. Messiaen T, Deret S, Mougenot B, et al. Adult Fanconi syndrome secondary to light chain gammopathy: clinicopathologic heterogeneity and unusual features in 11 patients. Medicine. 2000;79(3):135–154
  4. Herrera GA. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory. Ann Diagn Pathol. 2000;4:174–200
  5. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247–254
  6. Tomioka M, Ueki K, Nakahashi H, et al. Widespread crystalline inclusions affecting podocytes, tubular cells, and interstitial histiocytes in the myeloma kidney. Clin Nephrol. 2004;62(3):229–233
  7. Fogo AB, Kashgarian M. Tubulointerstitial diseases. In: Diagnostic Atlas of Renal Pathology: A Companion to Brenner and Rector's The Kidney. 7th ed.. Philadelphia, PA: Elsevier Ltd; 2005;p. 385–392
  8. Herrera GA, Picken MM. Renal diseases associated with plasma cell dyscrasias, amyloidoses, Waldenstrom macroglobulinemia, and cryoglobulinemic nephropathies. In:  Jennette JC,  Olson JL,  Schwartz MM,  Silva FG, et al. editor. Heptinstall's Pathology of the Kidney. Philadelphia, PA: Lippincott, Williams & Wilkins; 2007;p. 853–910
  9. Uchida S, Matsuda O, Yokota T, et al. Adult Fanconi syndrome secondary to kappa-light chain myeloma: improvement of tubular functions after treatment of myeloma. Nephron. 1990;55:332–335
  10. von Scheel C. Light chain myeloma with features of the adult Fanconi syndrome: six years remission following one course of melphalan. Acta Med Scand. 1976;199:533–537
  11. Stokes MB, Aronoff B, Siegel D, D'Agati VD. Dysproteinemia-related nephropathy associated with crystal-storing histiocytosis. Kidney Int. 2006;70:597–602
  12. Kapur U, Barton K, Fresco R, Leehy DJ, Picken MM. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy. Arch Pathol Lab Med. 2007;131:1368–1372
  13. Herrera GA, Joseph L, Gu X, Hough A, Barlogie B. Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2004;128:875–879
  14. Ma CX, Lacy MQ, Rompala JF, et al. Acquired Fanconi syndrome is an indolent disorder in the absence of overt multiple myeloma. Blood. 2004;104:40–42
  15. Carstens PH, Woo D. Crystalline glomerular inclusions in multiple myeloma. Am J Kidney Dis. 1989;14(1):56–60
  16. Yamamoto T, Hishida A, Honda N, Ito I, Shirasawa H, Nagase M. Crystal-storing histiocytosis and crystalline tissue deposition in multiple myeloma. Arch Pathol Lab Med. 1991;115:351–354
  17. Kowalewska J, Tomford RC, Alpers CE. Crystals in podocytes: an unusual manifestation of systemic disease. Am J Kidney Dis. 2003;42(3):605–611
  18. Matsuyama N, Joh K, Yamaguchi Y. Crystalline inclusions in the glomerular podocytes in a patient with benign monoclonal gammopathy and focal segmental glomerulosclerosis. Am J Kidney Dis. 1994;23:859–865
  19. Cai G, Sidhu GS, Wieczorek R, et al. Plasma cell dyscrasia with kappa light-chain crystals in proximal tubular cells: a histological, immunofluorescent, and ultrastructural study. Ultrastruc Pathol. 2006;30:315–319
  20. Confalonieri R, di Belgiojoso GB, Banfi G, et al. Light chain nephropathy: histological and clinical aspects in 15 cases. Nephrol Dial Transplant. 1988;2:150–156
  21. Noguchi K, Munemura C, Maeda S, et al. Myeloma-associated Fanconi syndrome due to λ-light chain crystal deposition. Yonago Acta Med. 2004;47:91–96
  22. Batuman V, Verroust PJ, Navar GL, et al. Myeloma light chains are ligands for cubilin (gp280). Am J Physiol. 1998;275:F246–F254
  23. Klassen RB, Allen PL, Batuman V, et al. Light chains are a ligand for megalin. J Appl Physiol. 2005;98:257–263
  24. Leboulleux M, Lelongt B, Mougenot B, et al. Protease resistance and binding of Ig light chains in myeloma-associated tubulopathies. Kidney Int. 1995;48:72–79
  25. Taneda S, Honda K, Horita S, et al. Proximal tubule cyoplasmic fibrillary inclusions following kidney transplantation in a patient with a paraproteinemia. Am J Kidney Dis. 2009;53(4):715–718
  26. Herrera GA, Sanders PW, Reddy V, Hasbargen JA, Hammond WS, Brooke JD. Ultrastructural immunolabeling: a unique diagnostic tool in monoclonal light chain-related renal disease. Ultrastruc Pathol. 1994;18:401–416
  27. Gu X, Barrios R, Cartwright J, Font RL, Truong L, Herrera GA. Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy. Hum Pathol. 2003;34(3):270–277

 Originally published online as doi:10.1053/j.ajkd.2009.08.010 on October 22, 2009.

PII: S0272-6386(09)01142-1

doi: 10.1053/j.ajkd.2009.08.010

American Journal of Kidney Diseases
Volume 55, Issue 6 , Pages 1136-1141 , June 2010